Actively Recruiting

Age: 18Years +
All Genders
NCT06828458

Determining Elements of Anti-Fungal Immunity in BURN Patients

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-23

327

Participants Needed

1

Research Sites

287 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Scientific justification Invasive fungal diseases (IFDs) pose a substantial threat, especially in immunocompromised patients, necessitating urgent research focus and therapeutic advancements. The IFI-BURN study, involving a cohort of patients with severe burn injury (n=276), revealed a significant IFD incidence of 31.6% and underscored their critical impact on morbidity and mortality. While fungi are present everywhere, for moulds within the environment and for yeasts within our microbiota, why certain patients develop IFDs and others do not, remains poorly understood. The answer most likely resides in the impact of the burn injury on the immune response, loss of skin barrier and particular predisposing immune phenotype of patients. The immune system is composed of both cellular and humoral components, but the latter is far less studied in antifungal immunity although they exert multiple antimicrobial mechanisms.

CONDITIONS

Official Title

Determining Elements of Anti-Fungal Immunity in BURN Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older
  • Admission less than 4 days following burn injury
  • Total burn surface area 15% or more
  • No opposition from the patient or relatives to participate
  • Affiliation to social security or any health insurance
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Opposition from the patient or relatives to participate
  • Decision not to resuscitate or to limit or stop active therapies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Saint Louis AP-HP

Paris, France

Actively Recruiting

Loading map...

Research Team

E

Emmanuel Dudoignon, MD

CONTACT

J

Jérôme Lambert, MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here